BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
T cell differentiation
,
Hepatitis
,
Leukocyte
,
Avian flu virus
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Bcl2-like
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Duodenum
Rectum colon
Leukocyte (polymorphonuclear) of peripheral blood
Colon
Adipose tissue subcutaneous
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Meningitis
Vesicular stomatitis Indiana virus disease
Ebola virus disease
Viral infections of the central nervous system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Butylhydroxybutylnitrosamine
Ethambutol
Floxuridine
Antigens, Neoplasm
glycidol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LEPR
LCP2
E4F1
ANG
PSEN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
TGF-beta/Smad3-dependent gene expression analysis in naive CD4 T cells
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
B-cells vrom BANK1 KO mice stimulated with CpG OGD
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Bcl2-like
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Re…
Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Me…
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Ne…
A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL…
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ